002044.CS▼3
Meinian Onehealth posts net loss of 182 million yuan in 2026 interim report
Meinian Onehealth released its 2026 interim report, showing total operating revenue of 3.844 billion yuan, down 6.45 percent from the same period last year, and a net loss attributable to the parent company of 182 million yuan. Net cash flow from operating activities was negative 429 million yuan, a decrease of 6.5829 million yuan compared with the same period last year. The company's asset-liability ratio was 53.35 percent, gross margin was 33.90 percent, return on equity was negative 2.29 percent, and diluted earnings per share was negative 0.05 yuan. Total asset turnover was 0.20 times, and inventory turnover was 14.64 times. The number of shareholders was 196,300, and the top ten shareholders held 32.88 percent of total share capital.